Edition:
United States

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

101.02USD
27 Mar 2017
Change (% chg)

$-2.80 (-2.70%)
Prev Close
$103.82
Open
$98.82
Day's High
$101.14
Day's Low
$98.82
Volume
125,207
Avg. Vol
76,416
52-wk High
$115.94
52-wk Low
$91.52

Latest Key Developments (Source: Significant Developments)

Bio-Techne Corp & Bio-Techne has entered into an exclusive license agreement
Tuesday, 7 Mar 2017 08:30am EST 

Bio-techne Corp : Bio-Techne Corp - Bio-Techne has entered into an exclusive license agreement with multiclonal therapeutics .Bio-Techne Corp - agreement to commercialize reagents and media systems in research reagent field.  Full Article

Bio-Techne Q2 adjusted earnings per share $0.81
Tuesday, 7 Feb 2017 07:30am EST 

Bio-techne Corp : Net sales for Q2 increased 9% to $131.8 million . Bio-Techne releases second quarter fiscal 2017 results . Q2 adjusted earnings per share $0.81 . Q2 gaap earnings per share $0.17 . Q2 revenue $131.8 million versus I/B/E/S view $134.5 million .Q2 earnings per share view $0.85 -- Thomson Reuters I/B/E/S.  Full Article

Bio-Techne reports Q1 GAAP earnings per share $0.44
Monday, 31 Oct 2016 08:00am EDT 

Bio-Techne Corp : Bio-Techne releases first quarter fiscal 2017 results . Q1 adjusted earnings per share $0.84 . Q1 GAAP earnings per share $0.44 . Q1 earnings per share view $0.79 -- Thomson Reuters I/B/E/S .Q1 sales $130.6 million versus I/B/E/S view $127.5 million.  Full Article

Bio-Techne posts Q4 adjusted EPS of $0.92
Wednesday, 17 Aug 2016 07:00am EDT 

Bio-techne Corp : Q4 adjusted earnings per share $0.92 . Q4 earnings per share view $0.96 -- Thomson Reuters I/B/E/S . Techne releases fourth quarter fiscal 2016 results . Q4 gaap earnings per share $0.69 . Q4 sales $134.8 million versus i/b/e/s view $129.2 million .Techne - in q4, incurred transactional foreign exchange losses due to fall of british pound and european commercial operations being based in uk.  Full Article

Bio-Techne signs credit agreement
Tuesday, 2 Aug 2016 08:50am EDT 

Bio-Techne Corp : On July 28, 2016, Bio-Techne Corp entered into a credit agreement - sec filing . Credit agreement matures on July 28, 2021 . Credit agreement provides for revolving credit facility of $400 million, which can be increased by additional $200 million subject to conditions .At closing on July 28, co drew $343.5 million on credit agreement in relation to closing of merger and for payment of outstanding debt.  Full Article

Bio-Techne to acquire Advanced Cell Diagnostics for $250 mln
Wednesday, 6 Jul 2016 05:37pm EDT 

Bio-techne Corp : Bio-Techne announces agreement to acquire advanced cell diagnostics . Techne -to acquire advanced cell diagnostics for $250 million in cash plus contingent consideration of $75 million due upon achievement of milestones . Techne corp - acquisition is expected to be accretive after 2017 . Techne corp - transaction will be financed through a combination of cash on hand and a revolving line of credit facility .Techne corp - acquisition is expected to be slightly dilutive to bio-techne's adjusted earnings per share for its fiscal year 2017.  Full Article

Bio-Techne to buy Space Import-Export Srl of Milan, Italy
Friday, 1 Jul 2016 04:30pm EDT 

Bio-Techne Corp: Techne Corp says to acquire Space Import-Export Srl of Milan, Italy .Bio-Techne- Space's Luca Cicchetti, will remain with Bio-Techne as managing director and lead Co's southern European commercial operations.  Full Article

Bio-Techne Corp declares dividend
Tuesday, 3 May 2016 07:00am EDT 

Bio-Techne Corp:Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2016.Quarterly dividend will be payable May 27, 2016 to all common shareholders of record on May 13, 2016.  Full Article

Bio-Techne Corp declares dividend
Tuesday, 2 Feb 2016 07:00am EST 

Bio-Techne Corp:Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2015.Quarterly dividend will be payable February 26, 2016 to all common shareholders of record on February 12, 2016.  Full Article

Bio-Techne Corp declares dividend
Thursday, 29 Oct 2015 04:00pm EDT 

Bio-Techne Corp:Says Board has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2015.Dividend will be payable November 27, 2015 to all common shareholders of record on November 13, 2015.  Full Article

More From Around the Web

BRIEF-Bio-Techne Corp & Bio-Techne has entered into an exclusive license agreement

* Bio-Techne Corp - Bio-Techne has entered into an exclusive license agreement with multiclonal therapeutics